We are monitoring the impact of COVID-19 on APAC Blood Screening Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 3178
Share on
Share on

Asia Pacific Blood Screening Market Research Report - By Technology, Product, End User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 3178
Pages: 150

APAC Blood Screening Market Size (2021 to 2026)

The size of the blood screening market in the Asia-Pacific is estimated to value USD 0.46 billion by 2026 and USD 0.31 billion in 2021, growing at a CAGR of 7.9% during the forecast period.

The development of new diseases, rising investment rates in advanced technology development, a growing elderly population, and favorable government blood screening regulations are all expected to enhance the blood screening market's growth in the Asia Pacific region. A blood screening is a medical procedure that involves examining blood for the presence of a certain disease or condition. It aids in the detection and prevention of diseases and several other problems such as infections and cancer.

Some other key factors driving the growth of the Asia Pacific blood screening market are an increase in the number of blood donations and blood donors, increased awareness about maintaining the safety of donated blood, increased prevalence of infectious diseases, increased awareness about health care, and an increase in the number of initiatives by various governments and government associations. During the forecast period, a large cancer patient pool combined with a rise in accidental cases is producing high demand for blood for their treatment, increasing the use of blood screening tests.

Increased healthcare spending, along with increased technology innovation, will fuel many of the new opportunities, propelling the blood screening industry forward. Pathogen reduction technology, microbiological screening, and multiplexing (a single test for HIV, HBV, and HCV) might help the blood screening market grow. Growing public awareness about the dangers of infectious illnesses in the blood, as a result of numerous initiatives, has resulted in a strong demand for blood screening tests in the Asia Pacific region. Accidents are becoming more common, and chronic diseases like cancer are becoming more common, resulting in a large need for blood for patient treatment.

The high costs of blood samples are expected to restrict the expansion of the blood screening industry. Complex regulatory frameworks for approval, a shortage of skilled workforce, the existence of competing technologies such as digital immunoassay, and expensive initial capital investment and testing expenses are all hindering the APAC blood screening market's growth.

Lack of legislation, regulation, and policies governing blood transfusion-related operations, as well as the development of alternative technologies to blood screening, is likely to limit the market's growth.

This research report on the APAC Blood Screening Market has been segmented and sub-segmented into the following categories:

By Technology: 

  • Nucleic Acid Amplification
  • Elisa
  • Rapid Test
  • NGS
  • Western Blotting

By Product: 

  • Instrument
  • Reagent & Kits
  • Software

By End User: 

  • Blood banks
  • Hospital

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regionally, the Asia-Pacific region is expected to expand in the near future due to improved access to treatment facilities and rising demand for government initiatives, advanced technology, higher adoption rates, and rising healthcare expenditure. The large pool of patients, improved health care infrastructure, increasing disposable income, growing demand for donated blood, and increased government support in APAC are the major drivers for the blood screening market in developing countries. Because of expanding public awareness about blood donation, patients' increasing buying power, and big corporations' growing interest in developing countries in the region, Asia Pacific is the fastest-growing region. In the Asia Pacific area, Japan, China, India, Australia, and Singapore are the major contributors. In addition, due to the advent of pathogen reduction technologies and the demand for multiplex testing, China and India are seen as emerging economies.

KEY MARKET PLAYERS:

Notable companies operating in the APAC Blood Screening Market profiled in the report are Becton, Dickinson and Company, Thermo Fisher Scientific Inc, Ortho Clinical Diagnostics, Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche Ltd, Grifols, Siemens AG, and Beckman Coulter, Inc.

1.Introduction          

                1.1 Market Definition      

                1.2 Study Deliverables    

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions  

2. Research Methodology    

                2.1 Introduction       

                2.2 Research Phases        

  2.2.1 Secondary Research                           

  2.2.2 Primary Research                 

  2.2.3 Econometric Modelling                      

  2.2.4 Expert Validation                  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview

                3.1 Executive Summary  

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints      

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation       

                5.1 Technology   

  5.1.1 Nucliec Acid Amplification Test                       

        6.3.1 Transcription-Mediated Amplification (TMA)           

        6.3.2 Real-Time Polymerase Chain Reaction (PCR             

  5.1.2 rCPR                           

  5.1.3 ELISA                         

        5.1.3.1 ELISA Market, By Platform            

      5.1.3.1.1 Chemiluminescence Immunoassay (CLIA)

      5.1.3.1.2 Fluorescence Immunoassay (FIA)

     5.1.3.1.3 Colorimetric Immunoassay (CI)

        5.1.3.2 ELISA Market, By Generation      

     5.1.3.2.1 First-Generation ELISA

     5.1.3.2.2 Second-Generation ELISA

     5.1.3.2.3 Third-Generation ELISA

     5.1.3.2.4 Fourth-Generation & Above

  5.1.4 CLIA                           

  5.1.5 Flourescence Assay                             

  5.1.6 Rapid Test 

  5.1.7 NGS                           

  5.1.8 Western Blotting                  

  5.1.9  Y-o-Y Growth Analysis, By Technology                       

  5.1.10  Market Attractiveness Analysis, By Technology                   

  5.1.11  Market Share Analysis, By Technology                    

                5.2 Product

  5.2.1 Instrument                             

        5.2.1.1 Rental Purchase

        5.2.1.2 Outright Purchase            

  5.2.2 Reagent and Kits                  

        5.2.2.1 NAT Reagents & Kits       

     5.2.2.1.1 Enzymes and Polymerases

     5.2.2.1.2 Standards and Controls

     5.2.2.1.3 Probes and Primers

     5.2.2.1.4 Buffers, Nucleotides and Solutions

     5.2.2.1.5 Labeling and Detection Reagents

        5.2.2.2 ELISA Reagents & Kits     

     5.2.2.2.1 Immunosorbents

      5.2.2.2.2 Controls

     5.2.2.2.3 Conjugates (Antigen Or Antibody-Conjugated Enzyme)

     5.2.2.2.4 Substrates (Of Enzymes)

     5.2.2.2.5 Sample Diluents and Wash Solutions

  5.2.3 Software                  

  5.2.4 Y-o-Y Growth Analysis, By Product 

  5.2.5 Market Attractiveness Analysis, By Product                             

  5.2.6 Market Share Analysis, By Product 

                5.3 End User        

  5.3.1 Blood Bank

  5.3.2 Hospital                    

  5.3.3 Y-o-Y Growth Analysis, By End User                             

  5.3.4  Market Attractiveness Analysis, By End User                          

  5.3.5  Market Share Analysis, By End User                            

  5.3.9  Market Share Analysis, By Application                       

6. Geographical Analysis       

                6.1 Introduction       

  6.1.1 Regional Trends                    

  6.1.2 Impact Analysis                     

  6.1.3 Y-o-Y Growth Analysis                        

        6.1.3.1 By Geographical Area     

        6.1.3.2 By Technology   

        6.1.3.3 By Product           

        6.1.3.4 By End User        

  6.1.4  Market Attractiveness Analysis                     

        6.1.4.1 By Geographical Area     

        6.1.4.2 By Technology   

        6.1.4.3 By Product           

        6.1.4.4 By End User        

  6.1.5  Market Share Analysis                      

        6.1.5.1 By Geographical Area     

        6.1.5.2 By Technology   

        6.1.5.3 By Product           

        6.1.5.4 By End User        

                6.2 China     

                6.3 India      

                6.4 Japan    

                6.5 South Korea       

                6.6 Australia        

7.Strategic Analysis 

                7.1 PESTLE analysis 

  7.1.1 Political                     

  7.1.2 Economic                 

  7.1.3 Social                         

  7.1.4 Technological                         

  7.1.5 Legal                          

  7.1.6 Environmental                       

                7.2 Porter’s Five analysis      

  7.2.1 Bargaining Power of Suppliers                        

  7.2.2 Bargaining Power of Consumers                    

  7.2.3 Threat of New Entrants                     

  7.2.4 Threat of Substitute Products and Services

  7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis  

                8.1 Grifols   

  8.1.1 Overview                 

  8.1.2 Product Analysis                   

  8.1.3 Financial analysis                  

  8.1.4 Recent Developments                       

  8.1.5 SWOT analysis                       

  8.1.6 Analyst View                          

                8.2 Thermo Fisher Scientific

                8.3 Roche Diagnostics      

                8.4 BioMerieux  

                8.5 Bio-Rad Laboratories      

                8.6 Siemens Heathineers     

                8.7 Abbott Laboratories       

                8.8 Ortho Clinical diagnostics        

                8.9 Becton  

                8.10 Dickinson and Company       

                8.11 Beckman Coulter     

9.Competitive Landscape     

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis         

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities   

Appendix    

                a) List of Tables  

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • to provide both individuals and organizations a strong financial foothold in the marketInvestment opportunitiesExpertly devised analyst overview along with
  •  
  1. Asia-Pacific Blood Screening Market, By Technology, From 2021 to 2026 (USD Million)
  2. Asia-Pacific Nucliec Acid Amplification Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia-Pacific rCPR Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia-Pacific ELISA Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia-Pacific CLIA Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia-Pacific Flourescence Assay Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia-Pacific Rapid Test Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia-Pacific NGS Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia-Pacific Western Blotting Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia-Pacific Blood Screening Market, By Product, From 2021 to 2026 (USD Million)
  11. Asia-Pacific Instrument Market, By Region, From 2021 to 2026 (USD Million)
  12. Asia-Pacific Reagent and Kits Market, By Region, From 2021 to 2026 (USD Million)
  13. Asia-Pacific Software Market, By Region, From 2021 to 2026 (USD Million)
  14. Asia-Pacific Blood Screening Market, By End User, From 2021 to 2026 (USD Million)
  15. Asia-Pacific Blood Bank Market, By Region, From 2021 to 2026 (USD Million)
  16. Asia-Pacific Hospital Market, By Region, From 2021 to 2026 (USD Million)
  17. Japan Blood Screening Market, By Technology, From 2021 to 2026 (USD Million)
  18. Japan Blood Screening Market, By Product, From 2021 to 2026 (USD Million)
  19. Japan Blood Screening Market, By End User, From 2021 to 2026 (USD Million)
  20. China Blood Screening Market, By Technology, From 2021 to 2026 (USD Million)
  21. China Blood Screening Market, By Product, From 2021 to 2026 (USD Million)
  22. China Blood Screening Market, By End User, From 2021 to 2026 (USD Million)
  23. India Blood Screening Market, By Technology, From 2021 to 2026 (USD Million)
  24. India Blood Screening Market, By Product, From 2021 to 2026 (USD Million)
  25. India Blood Screening Market, By End User, From 2021 to 2026 (USD Million)
  26. Australia Blood Screening Market, By Technology, From 2021 to 2026 (USD Million)
  27. Australia Blood Screening Market, By Product, From 2021 to 2026 (USD Million)
  28. Australia Blood Screening Market, By End User, From 2021 to 2026 (USD Million)
  29. South Korea Blood Screening Market, By Technology, From 2021 to 2026 (USD Million)
  30. South Korea Blood Screening Market, By Product, From 2021 to 2026 (USD Million)
  31. South Korea Blood Screening Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample